IL-2 and IL-4 Serum Levels in Breast Cancer

IL-2 and IL-4 Serum Levels in Breast Cancer

Background: The role of cytokines in cancer immunity and carcinogenesis in general has been well established, which play an important role in the pathogenesis of many solid cancers.This study aimed to estimate serum levels of IL-2 and IL-4, and to shed light on the correlation of these interleukins...

Full description

Bibliographic Details
Main Author:	Batool H. Al-Ghurabi
Format:	Article
Language:	English
Published:	College of Medicine University of Baghdad 2009-10-01
Series:	مجلة كلية الطب
Subjects:	Breast cancer, Cytokines, ER
Online Access:	http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1130

Similar Items

Serum Levels of IL-22 and ACPA in Patients with Rheumatoid Arthritis
by: Zainab A. Aldhaher, et al.
Published: (2018-06-01)

Interleukine-2 serum level in breast cancer patients
by: Tutik Harjianti, et al.
Published: (2023-05-01)

The role of serum IL-6 in colorectal cancer patients and it’s relationship with serum CEA level
by: Batool H. Al-Ghurabi, et al.
Published: (2010-01-01)

IFN-γ, IL-4 and IL-17 Concentration in Tumor Tissue, Adjacent Tumor Tissue and the Serums of Patients with Breast Cancer
by: Alireza Andalib, et al.
Published: (2011-12-01)

Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients
by: Gang Liu, et al.
Published: (2022-12-01)

Measuring the level of IL-4 and IL-25 in the serum of eczema patients
by: Ali Mohammed Abd AL-Ameer, et al.
Published: (2023-09-01)

A Survey of the Relationship between Serum Testosterone Level and Expressions of Androgen, Progesterone and Estrogen Receptors and HER2 in Iranian Women with Breast Cancer
by: Reza Vojdani, et al.
Published: (2015-07-01)

The Role of PPARs in Breast Cancer
by: Binggong Zhao, et al.
Published: (2022-12-01)

Estrogens and the risk of breast cancer: A narrative review of literature
by: Khayry Al-Shami, et al.
Published: (2023-09-01)

Estrogen Receptor Signaling in Breast Cancer
by: Paulina Miziak, et al.
Published: (2023-09-01)

Increased Expression of Estrogen Receptor α-36 by Breast Cancer Oncogene IKKε Promotes Growth of ER-Negative Breast Cancer Cells
by: Qihong Li, et al.
Published: (2013-06-01)

Low serum gastrin associated with ER+ breast cancer development via inactivation of CCKBR/ERK/P65 signaling
by: Li-Li Meng, et al.
Published: (2018-08-01)

Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status
by: Ganiyu Olatunbosun Arinola, et al.
Published: (2021-10-01)

Investigating the Effect of Endurance Training on Tumor Level of IL-8 and Serum Level of IL-17 in Female Mice with Breast Cancer
by: AR Kazemi, et al.
Published: (2015-11-01)

Investigating the Effect of Endurance Training on Tumor Level of IL-8 and Serum Level of IL-17 in Female Mice with Breast Cancer
by: AR Kazemi, et al.
Published: (2015-11-01)

Serum Levels of Il-12 and Il-23 in Breast Cancer Patients Infected with Toxoplasma gondii: A Case-Control Study
by: Maha Mustafa ASSIM, et al.
Published: (2020-12-01)

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
by: Suryavathi Viswanadhapalli, et al.
Published: (2019-12-01)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
by: Rainer Girgert, et al.
Published: (2019-01-01)

The hormonal milieu in primary breast cancer: A correlation between steroid receptors and serum estradiol, progesterone and prolactin
by: Mehryar Zargari
Published: (2013-09-01)

Mitochondria-Associated Endoplasmic Reticulum Membranes in Breast Cancer
by: Hongjiao Yu, et al.
Published: (2021-01-01)

Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer
by: Jin J, et al.
Published: (2024-01-01)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
by: Jharna Datta, et al.
Published: (2022-04-01)

Evaluation of serum levels of Proinflammatory Cytokines IL-8, IL-17, and IL-22 in Helicobacter pylori infection and their association with the degree of gastritis histopathology in a sample of Iraqi patients
by: Miriam Jasim Shehab, et al.
Published: (2023-06-01)

PROMOTOR POLYMORPHISM OF IL-4, IL-6, AND IL-10 GENES AMONG PATIENTS WITH BREAST CANCER
by: A. V. Shevchenko, et al.
Published: (2014-07-01)

The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer
by: Carlos Martínez-Pérez, et al.
Published: (2021-10-01)

Changes in the Serum Levels of Cytokines: IL-1β, IL-4, IL-8 and IL-10 in Depression with and without Posttraumatic Stress Disorder
by: Ewa Ogłodek
Published: (2022-03-01)

The Effect of 8 Weeks Endurance Training on Serum Levels of IL-10 and IL-8, and White Blood Cell Count in Women with Breast Cancer
by: Abdolreza Kazemi, et al.
Published: (2016-08-01)

Screening 2‒mercaptoimidazole derivatives for breast cancer treatment
by: Tran Viet Anh, et al.
Published: (2023-11-01)

Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers
by: Linda A. Schuler, et al.
Published: (2021-07-01)

Defective Signalling of the BRCA1 Neighbouring gene, NBR2, leads to ER-? Negative tumours in breast cancer xenograft mouse models
by: Dipyaman Patra, et al.
Published: (2022-12-01)

Trefoil factor 3 isolated from human breast milk downregulates cytokines (IL8 and IL6) and promotes human beta defensin (hBD2 and hBD4) expression in intestinal epithelial cells HT-29
by: Girolamo Jose Barrera, et al.
Published: (2012-11-01)

Development of a nomogram based on serum cytokine-related riskscore in breast cancer
by: Ye Zhu, et al.
Published: (2023-03-01)

The Role of CD4/6 Inhibitors in Breast Cancer Treatment
by: Luv Purohit, et al.
Published: (2024-01-01)

Assessment of the serum level of IL-1B, IL-2, and IL-10 in children infected with Enterobius vermicularis in Babylon province
by: Aseel Sekar Naji AL-Bairmani, et al.
Published: (2023-01-01)

Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR
by: Nandini Dey, et al.
Published: (2021-01-01)

IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer
by: Olena Kourko, et al.
Published: (2019-10-01)

Modulation of Nrf2 by Activation of Estrogen Receptor β as a Therapeutic Strategy to Prevent Cancer Development and Overcome Inflammation-Related Drug Resistance in Breast Cancer
by: Emdormi Rymbai, et al.
Published: (2023-01-01)

Expression of Biomarkers CXCR4, IL11-RA, TFF1, MLF1P in Advanced Breast Cancer Patients with Bone Metastatic: a Diagnostic Study
by: Cosphiadi Irawan, et al.
Published: (2017-02-01)

The Study of HER-2/neu, ER/PR Expression Using Immunohistochemistry (IHC) in the Iraqi Breast Cancer
by: Suhad Faisal Hatem, et al.
Published: (2016-06-01)

Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15
by: Abdolkarim Sheikhi, et al.
Published: (2016-09-01)